Scarica l'app Stockscreener
85.49
1.75%
1.47
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GH Giù?
Forum
Previsione
Guardant Health Inc Borsa (GH) Ultime notizie
Shield Progress Draws Attention To Guardant Health’s Valuation And Risks - Yahoo Finance UK
Guardant Health (GH) Valuation Check As Shield Across America Expands Colorectal Cancer Screening Reach - simplywall.st
Biotech Stock Up 685% Draws $80.5 Million Investment Amid Dual FDA Filings - The Motley Fool
Liquid Biopsy Market to Reach US$28.20 Billion by 2033 at 12.8% - openPR.com
New Guardant Health/Harris Poll Survey Shows 92% of All Eligible Americans Believe Colorectal Cancer Blood Tests Should be Accessible and Covered Similar to Medicare - WFMZ.com
Guardant Health (GH) CTO awarded 23,856 time‑vested RSUs - Stock Titan
BIAF vs. GH: Which cancer detection stock is the better buy now? - MSN
Guardant Health Is Riding Shield’s Fast Screening Ramp - Finimize
Quest Diagnostics Expands Preventive Reach With Shield Colorectal Blood Test - simplywall.st
Capital International Investors Sells 287,217 Shares of Guardant Health, Inc. $GH - MarketBeat
Guardant Health, Inc. (NASDAQ:GH) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Guardant Health at Leerink Global Healthcare: Strategic Growth and Partnerships - Investing.com Canada
Guardant Health's Shield Blood-based Screening Test for Colorectal Cancer Now Accessible Through National Test Ordering and Collection Network of Quest Diagnostics - National Today
Guardant Health’s Shield Blood-based Screening Test for Colorectal Cancer Now Accessible Through National Test Ordering and Collection Network of Quest Diagnostics - Business Wire
Hidalgo Medina sells Guardant Health (GH) shares for $118,996 By Investing.com - Investing.com India
Hidalgo Medina sells Guardant Health (GH) shares for $118,996 - Investing.com
Guardant Health (NASDAQ:GH) Director Medina Manuel Hidalgo Sells 1,300 Shares - MarketBeat
Guardant Health (GH) director sells 1,300 shares after option exercise - Stock Titan
Victory Capital Management Inc. Cuts Stake in Guardant Health, Inc. $GH - MarketBeat
Rhenman & Partners Asset Management Invests in Guardant Health - National Today
Rhenman & Partners Asset Management AB Makes New Investment in Guardant Health, Inc. $GH - MarketBeat
(GH) Movement as an Input in Quant Signal Sets - Stock Traders Daily
How geopolitical risks impact Guardant Health Inc. (5GH) stockWeekly Trade Recap & Fast Exit/Entry Strategy Plans - Naître et grandir
[144] Guardant Health, Inc. SEC Filing - Stock Titan
Guardant Health Tour Highlights Colorectal Test Uptake And Valuation Gap - Yahoo Finance
BIAF vs. GH: Which Cancer Detection Stock Is the Better Buy Now? - Finviz
TEM's Diagnostics Arm Expanding Rapidly: What's Driving the Growth? - Yahoo Finance
Legato Capital Management LLC Has $677,000 Position in Guardant Health, Inc. $GH - MarketBeat
Amova Asset Management Americas Inc. Has $47.12 Million Position in Guardant Health, Inc. $GH - MarketBeat
ARK Investment Management LLC Sells 2,028,263 Shares of Guardant Health, Inc. $GH - MarketBeat
Analysts Offer Insights on Healthcare Companies: Guardant Health (GH) and 908 Devices (MASS) - The Globe and Mail
Guardant Health Targets Early Detection Growth With New Partner And Acquisition - simplywall.st
Shield mobile tour brings FDA-approved screening to 100 communities, Guardant Health announces - Traders Union
Guardant Health Launches Coast-to-Coast Screening Tour, Bringing Shield Colon Cancer Blood Test to Over 100 Communities Across America - Guardant Health
Segall Bryant & Hamill LLC Increases Stock Position in Guardant Health, Inc. $GH - MarketBeat
Guardant Health Launches Coast-to-Coast Screening Tour, Bringing - GuruFocus
Actor and Cancer Advocate Patrick Dempsey Partners with Guardant Health to Raise Awareness about Colorectal Cancer Screening and Shield Blood Test, Sharing His Experience Getting Screened - Guardant Health
GH Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Intech Investment Management LLC Has $3.19 Million Stock Holdings in Guardant Health, Inc. $GH - MarketBeat
TD Asset Management Boosts Guardant Health Holdings - National Today
Guardant Health (GH) director acquires 154 shares via RSU vesting - Stock Titan
Guardant Health, Inc. (GH) Stock Analysis: A 41% Upside Potential With Strong Buy Ratings - DirectorsTalk Interviews
Does Guardant’s 2026 Outlook And Shelf Filing Reshape The Bull Case For Guardant Health (GH)? - simplywall.st
TD Asset Management Inc Boosts Holdings in Guardant Health, Inc. $GH - MarketBeat
Guardant Health, Inc. (GH) Strengthens Health Technology Portfolio with MetaSight Diagnostics Acquisition - Bitget
TD Cowen Health Care Conference - marketscreener.com
Guardant Health (GH) Is Down 8.9% After Issuing 2026 Guidance And New Equity Shelf Registration – Has The Bull Case Changed? - Yahoo Finance
Clover Health, Alignment Healthcare, Solventum, ANI Pharmaceuticals, and Guardant Health Shares Plummet, What You Need To Know - The Globe and Mail
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - ChartMill
Erste Asset Management GmbH Buys 66,617 Shares of Guardant Health, Inc. $GH - MarketBeat
Colon cancer screening expands with simple blood test as cases rise among under-50s - WLUK
0.34%
0.59%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):